Dexcom
Logotype for Dexcom Inc

Dexcom (DXCM) investor relations material

Dexcom Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Dexcom Inc
Q4 2025 earnings summary12 Feb, 2026

Executive summary

  • Q4 2025 revenue reached $1.26 billion, up 13% year-over-year, driven by strong new customer demand and the G7 15-Day product launch.

  • CEO outlined strategic priorities: premier glucose sensing, customer experience leadership, and international expansion.

  • Operational improvements in manufacturing, logistics, and supply chain led to higher inventory and reduced sensor issues.

  • Stelo contributed $130 million in 2025 revenue, with new app features planned for 2026.

  • FDA clearance for Smart Basal and launch of G7 15-Day CGM in the U.S.

Financial highlights

  • Q4 2025 worldwide revenue: $1.26 billion; U.S. revenue: $892 million (+11%), international revenue: $368 million (+18%).

  • Q4 non-GAAP gross profit: $799.8 million (63.5% margin), up from 59.4% in Q4 2024.

  • Q4 non-GAAP operating income: $331.5 million (26.3% margin), up from $209.5 million (18.8%) in Q4 2024.

  • Adjusted EBITDA: $422.2 million (33.5% margin), up from $300.1 million (27.0%) in Q4 2024.

  • Q4 GAAP net income: $267.3 million ($0.68 per share), up from $151.7 million ($0.38) in Q4 2024.

Outlook and guidance

  • 2026 revenue guidance: $5.16–$5.25 billion, representing 11–13% growth, with incremental contributions from Stelo and new products.

  • Full-year 2026 non-GAAP gross margin expected at 63–64%, operating margin at 22–23%, and adjusted EBITDA margin at 30–31%.

  • Margin expansion expected from lower freight costs, manufacturing efficiencies, and G7 15-Day contributions.

  • Investments planned for sales, innovation, and Ireland manufacturing facility launch in late 2026.

What market share gains are expected from Smart Basal?
Detail drivers of 2025 operating margin expansion.
How will $2B cash fund new market opportunities?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Dexcom earnings date

Logotype for Dexcom Inc
Q1 202630 Apr, 2026
Dexcom
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Dexcom earnings date

Logotype for Dexcom Inc
Q1 202630 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Dexcom, Inc., focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company's products include Dexcom G4 PLATINUM System, Dexcom G5 Mobile CGM System, and its interoperable systems, as well as other clinical diagnostic products. It offers its products to hospitals; physicians' offices specializing in diabetes treatment; ambulatory surgical centers; clinical practice settings; corporate wellness programs; and individual patients. The company markets its products directly to physicians and their specialties, including endocrinologists; general practitioners; obstetricians/gynecologists; pediatricians; family physicians; doctors practicing in health care clinics or managed facilities; diabetologists; and internists. The company was incorporated in 1999.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage